NM_006030.4:c.3158C>A

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_006030.4(CACNA2D2):​c.3158C>A​(p.Pro1053Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,459,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1053L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

CACNA2D2
NM_006030.4 missense

Scores

4
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 6.48

Publications

0 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
NM_006030.4
MANE Select
c.3158C>Ap.Pro1053Gln
missense
Exon 36 of 38NP_006021.2
CACNA2D2
NM_001174051.3
c.3179C>Ap.Pro1060Gln
missense
Exon 37 of 39NP_001167522.1
CACNA2D2
NM_001005505.3
c.3158C>Ap.Pro1053Gln
missense
Exon 36 of 38NP_001005505.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
ENST00000424201.7
TSL:1 MANE Select
c.3158C>Ap.Pro1053Gln
missense
Exon 36 of 38ENSP00000390329.2
CACNA2D2
ENST00000423994.6
TSL:5
c.3182C>Ap.Pro1061Gln
missense
Exon 37 of 39ENSP00000407393.2
CACNA2D2
ENST00000479441.1
TSL:1
c.3179C>Ap.Pro1060Gln
missense
Exon 37 of 39ENSP00000418081.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1459878
Hom.:
0
Cov.:
36
AF XY:
0.00000138
AC XY:
1
AN XY:
726276
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33460
American (AMR)
AF:
0.00
AC:
0
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51852
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111708
Other (OTH)
AF:
0.00
AC:
0
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Benign
-0.32
CADD
Pathogenic
30
DANN
Benign
0.97
DEOGEN2
Benign
0.011
T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.053
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.94
D
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.30
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.0
L
PhyloP100
6.5
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.28
N
REVEL
Benign
0.10
Sift
Benign
0.24
T
Sift4G
Benign
0.60
T
Polyphen
0.025
B
Vest4
0.57
MutPred
0.37
Loss of sheet (P = 0.0817)
MVP
0.21
MPC
0.85
ClinPred
0.83
D
GERP RS
4.7
Varity_R
0.11
gMVP
0.37
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.36
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.36
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757572722; hg19: chr3-50402556; API